Sulindac sulfide induces apoptosis by both Cox-2 dependent and Cox-2 independent mechanisms and inhibits proliferation by a Cox-2 independent mechanism

被引:0
|
作者
Agarwal, B [1 ]
Swaroop, P [1 ]
Protiva, P [1 ]
Bhendwal, S [1 ]
Ramey, WR [1 ]
Shirin, H [1 ]
Feoktistov, AS [1 ]
Holt, PR [1 ]
机构
[1] St Lukes Roosevelt Hosp Ctr, New York, NY USA
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
G1615
引用
收藏
页码:A369 / A369
页数:1
相关论文
共 50 条
  • [41] Cox-2: where are we in 2003? - Cardiovascular risk and Cox-2 inhibitors
    Debabrata Mukherjee
    Eric J Topol
    Arthritis Res Ther, 5
  • [42] Inhibition of polyamine production by Celecoxib and Sulindac: A COX-2 independent pathway in bladder cancer
    Gee, Jason R.
    Burmeister, Corrie B.
    CANCER RESEARCH, 2006, 66 (08)
  • [43] Evaluation of the antineoplastic properties of COX-2 selective inhibitors in human breast and prostate tumor cell lines: evidence for a COX-2 independent mechanism
    Piazza, G
    Estlack, L
    Quada, J
    Agyin, J
    Izbicka, E
    Tocher, A
    Oyajobi, B
    Mundy, G
    EUROPEAN JOURNAL OF CANCER, 2002, 38 : S85 - S85
  • [44] Is COX-2 a perpetrator or a protector? Selective COX-2 inhibitors remain controversial
    Luo, C
    He, ML
    Bohlin, L
    ACTA PHARMACOLOGICA SINICA, 2005, 26 (08) : 926 - 933
  • [45] Glycosylation of cyclooxygenase-2 (COX-2) influences effectiveness of COX-2 inhibitors
    Graham, Kamara Whitney
    Sevigny, Mary B.
    Gabriel, Bianca S.
    FASEB JOURNAL, 2009, 23
  • [46] Is COX-2 a perpetrator or a protector? Selective COX-2 inhibitors remain controversial
    Cheng Luo
    Ming-liang He
    Lars Bohlin
    Acta Pharmacologica Sinica, 2005, 26 : 926 - 933
  • [47] Cox-2 is needed but not sufficient for apoptosis induced by Cox-2 selective inhibitors in colon cancer cells
    Agarwal, B
    Swaroop, P
    Protiva, P
    Raj, SV
    Shirin, H
    Holt, PR
    APOPTOSIS, 2003, 8 (06) : 649 - 654
  • [48] Cox-2 is needed but not sufficient for apoptosis induced by Cox-2 selective inhibitors in colon cancer cells
    B. Agarwal
    P. Swaroop
    P. Protiva
    S. V. Raj
    H. Shirin
    P. R. Holt
    Apoptosis, 2003, 8 : 649 - 654
  • [50] Evaluation of COX-1/COX-2 selectivity and potency of a new class of COX-2 inhibitors
    Gierse, James
    Nickols, Maureen
    Leahy, Kathleen
    Warner, James
    Zhang, Yan
    Cortes-Burgos, Luz
    Carter, Jeffery
    Seibert, Karen
    Masferrer, Jaime
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2008, 588 (01) : 93 - 98